Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells.

Haveman LM, Bierings M, Klein MR, Beekman JM, de Jager W, Kuis W, Albani S, Prakken BJ.

Clin Immunol. 2013 Mar;146(3):228-39. doi: 10.1016/j.clim.2013.01.002. Epub 2013 Jan 16.

PMID:
23416239
2.

Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction.

Heemskerk B, van Vreeswijk T, Veltrop-Duits LA, Sombroek CC, Franken K, Verhoosel RM, Hiemstra PS, van Leeuwen D, Ressing ME, Toes RE, van Tol MJ, Schilham MW.

J Immunol. 2006 Dec 15;177(12):8851-9.

3.

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.

Feuchtinger T, Matthes-Martin S, Richard C, Lion T, Fuhrer M, Hamprecht K, Handgretinger R, Peters C, Schuster FR, Beck R, Schumm M, Lotfi R, Jahn G, Lang P.

Br J Haematol. 2006 Jul;134(1):64-76.

PMID:
16803570
4.

Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.

Feuchtinger T, Richard C, Pfeiffer M, Neuhäuser F, Lücke J, Handgretinger R, Greil J, Bader P, Klingebiel T, Schlegel PG, Jahn G, Niethammer D, Lang P.

Klin Padiatr. 2005 Nov-Dec;217(6):339-44.

PMID:
16307420
5.

Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.

Feuchtinger T, Richard C, Joachim S, Scheible MH, Schumm M, Hamprecht K, Martin D, Jahn G, Handgretinger R, Lang P.

J Immunother. 2008 Feb-Mar;31(2):199-206. doi: 10.1097/CJI.0b013e31815ef862.

PMID:
18481389
6.

T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors.

Comoli P, Schilham MW, Basso S, van Vreeswijk T, Bernardo ME, Maccario R, van Tol MJ, Locatelli F, Veltrop-Duits LA.

J Immunother. 2008 Jul-Aug;31(6):529-36. doi: 10.1097/CJI.0b013e31817b9c6b.

PMID:
18528302
7.

Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.

Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G, Niethammer D, Einsele H.

Exp Hematol. 2004 Mar;32(3):282-9.

PMID:
15003314
8.

Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation.

Serangeli C, Bicanic O, Scheible MH, Wernet D, Lang P, Rammensee HG, Stevanovic S, Handgretinger R, Feuchtinger T.

Virology. 2010 Feb 20;397(2):277-84. doi: 10.1016/j.virol.2009.10.049. Epub 2009 Dec 3.

9.

Human CD4+ T cells stimulated by conserved adenovirus 5 hexon peptides recognize cells infected with different species of human adenovirus.

Veltrop-Duits LA, Heemskerk B, Sombroek CC, van Vreeswijk T, Gubbels S, Toes RE, Melief CJ, Franken KL, Havenga M, van Tol MJ, Schilham MW.

Eur J Immunol. 2006 Sep;36(9):2410-23.

10.

Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.

Zandvliet ML, van Liempt E, Jedema I, Kruithof S, Kester MG, Guchelaar HJ, Falkenburg JH, Meij P.

J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90.

PMID:
21389867
11.

Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.

Heemskerk B, Lankester AC, van Vreeswijk T, Beersma MF, Claas EC, Veltrop-Duits LA, Kroes AC, Vossen JM, Schilham MW, van Tol MJ.

J Infect Dis. 2005 Feb 15;191(4):520-30. Epub 2005 Jan 7.

PMID:
15655775
12.

In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.

La Rosa C, Wang Z, Lacey SF, Lalimarmo MM, Krishnan A, Longmate J, Diamond DJ.

Exp Hematol. 2006 Apr;34(4):497-507.

PMID:
16569596
13.

Capture and generation of adenovirus specific T cells for adoptive immunotherapy.

Chatziandreou I, Gilmour KC, McNicol AM, Costabile M, Sinclair J, Cubitt D, Campbell JD, Kinnon C, Qasim W, Gaspar HB.

Br J Haematol. 2007 Jan;136(1):117-26. Epub 2006 Nov 8.

PMID:
17092305
14.

Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.

Papanicolaou GA, Latouche JB, Tan C, Dupont J, Stiles J, Pamer EG, Sadelain M.

Blood. 2003 Oct 1;102(7):2498-505. Epub 2003 Jun 12.

15.

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.

Wong R, Lau R, Chang J, Kuus-Reichel T, Brichard V, Bruck C, Weber J.

Clin Cancer Res. 2004 Aug 1;10(15):5004-13.

16.

Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application.

Geyeregger R, Freimüller C, Stevanovic S, Stemberger J, Mester G, Dmytrus J, Lion T, Rammensee HG, Fischer G, Eiz-Vesper B, Lawitschka A, Matthes S, Fritsch G.

PLoS One. 2013 Apr 22;8(4):e59592. doi: 10.1371/journal.pone.0059592. Print 2013.

17.

Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide.

Einsele H, Rauser G, Grigoleit U, Hebart H, Sinzger C, Riegler S, Jahn G.

Cytotherapy. 2002;4(1):49-54.

PMID:
11953041
18.

Attenuation of CD4+ T-cell function by human adenovirus type 35 is mediated by the knob protein.

Adams WC, Berenson RJ, Karlsson Hedestam GB, Lieber A, Koup RA, Loré K.

J Gen Virol. 2012 Jun;93(Pt 6):1339-44. doi: 10.1099/vir.0.039222-0. Epub 2012 Feb 22.

PMID:
22357750
19.
20.

Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells.

Melenhorst JJ, Solomon SR, Shenoy A, Hensel NF, McCoy JP Jr, Keyvanfar K, Barrett AJ.

J Immunother. 2006 Jul-Aug;29(4):436-43; discussion 365-6.

PMID:
16799339

Supplemental Content

Support Center